AbbVie ’s next potential blockbuster wins approval in Japan

With AbbVie ’s top-selling Humira headed for the patent cliff, the company is gaining momentum for a global rollout of its next potential blockbuster.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news